Oregon's strategy to confront prescription opioid misuse: A case study

Journal of Substance Abuse Treatment

Volumn 48, Issue 1, 2015, Pages 91-95

  McCarty, Dennis ^a   Bovett, Rob ^b   Burns, Thomas ^c   Cushing, Judy ^d   Glynn, Mary Ellen ^e   Kruse, Senator Jeff ^f   Millet, Lisa M ^c   Shames, Jim ^g  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^b Lincoln County District Attorney's Office   (United States)

^c OREGON HEALTH AUTHORITY   (United States)

^d Lines for Life   (United States)

^e Oregon Association of Relief Nurseries   (United States)

^f Oregon State Legislative Assembly   (United States)

^g Jackson County Health Department   (United States)

Author keywords

Prescriber education; Prescription drug monitoring program; Prescription opioids

Indexed keywords

ALCOHOL; OPIATE; PRESCRIPTION DRUG; NARCOTIC ANALGESIC AGENT;

ARTICLE; CASE STUDY; CONSENSUS DEVELOPMENT; DRUG LEGISLATION; DRUG MISUSE; HEALTH CARE POLICY; HUMAN; INTRACTABLE PAIN; OPIATE ADDICTION; PILL; POLICY; PRESCRIPTION; PRIORITY JOURNAL; UNITED STATES; WASTE DISPOSAL; DRUG MONITORING; LEGISLATION AND JURISPRUDENCE; OPIOID-RELATED DISORDERS; OREGON; PRESCRIPTION DRUG MISUSE; STANDARDS;

ANALGESICS, OPIOID; DRUG MONITORING; DRUG PRESCRIPTIONS; HUMANS; OPIOID-RELATED DISORDERS; OREGON; PRESCRIPTION DRUG MISUSE; PUBLIC POLICY;

EID: 84922804834     PISSN: 07405472     EISSN: 18736483     Source Type: Journal    
DOI: 10.1016/j.jsat.2014.07.012     Document Type: Article

References (8)

1. Department of Justice, Drug Enforcement Administration Disposal of controlled substances: Proposed rule. Federal Register 2012, 77(246):75784-75817. (December 21, 2012).
2. Deyo R.A., Irvine J.M., Millet L.M., Beran T., O'Kane N., Wright D.A., et al. Measures susch as interstate cooperation would improve the efficacy of programs to track controlled drug prescriptions. Health Affairs 2013, 32(3):603-613.
3. Food and Drug Administration FDA blueprint for prescriber education for extended-release and long-acting opioid analgesics 2013, (Available on-line: http://www.fda.gov/downloads/drugs/drugsafety/informationbydrugclass/ucm277916.pdf).
4. McConnell K.J., Chang A.M., Cohen D.J., Wallace N., Chernew M.E., Kautz G., et al. Oregon's Medicaid transformation: An innovative approach to holding a health system accountable for spending growth. Healthcare 2014, (on-line in advance of print). 10.1016/j.hjdsi.2013.11.002.
5. Millet L. Prescription opioid overdose & misuse in Oregon. Presentation to the Prescription Drug Misuse Meeting, Salem, OR, December 5, 2012 2012, (Available at: http://www.orpdmp.com/orpdmpfiles/PDF_Files/Reports/NGA-overdose-presentation_Millet_12-05-2012.pdf).
6. National Quality Forum National voluntary consensus standards for the treatment of substance use conditions: Evidence-based treatment practices 2007, National Quality Forum, Washington, DC.
7. Stecker E.C. The Oregon ACO experiment-Bold design, challenging execution. The New England Journal of Medicine 2013, 368(11):982-985.
8. Substance Abuse and Mental Health Services Administration The NSDUH Report: State Estimates of Nonmedical Use of Prescription Pain Relievers, Rockville, MD 2012, (Available at: http://www.samhsa.gov/data/2k12/NSDUH115/sr115-nonmedical-use-pain-relievers.htm).